No Members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity with the exception of the following faculties:

  • Dr. Narjust Duma: Dr. Duma has served as consultant for the following ineligible companies: Pfizer, AstraZeneca, Jansen and Neogenomics/inivata.
  • Dr. Christina Baik: Dr. Baik has received research support from Celgene. In addition, research funding was provided by the following ineligible companies to the University of Washington, and not directly to Dr. Baik: BMS, Merck and Genentech.  
  • Dr. Sandip Patel: Dr. Patel has received research support and served as consultants for the following ineligible companies: BMS, Merck, Roche/Genentech, AstraZeneca?MedImmune, Pfizer

All relevant financial relationships of individuals in control of the content have been identified and mitigated. 

No part of this activity will include the discussion of unapproved or investigational products. 


This activity has been supported with an independent medical education grant from AstraZeneca, Inc.